Biosimilars

Vision is one of our most vital senses — yet millions around the world are at risk of losing it due to chronic and progressive eye diseases. Conditions such as diabetic retinopathy and age-related macular degeneration (AMD) are rising sharply, driven by aging populations and increasing rates of diabetes.

At Biocon Biologics, we are committed to protecting sight and preserving quality of life. Through advanced biologics and biosimilars, we aim to make high-quality, affordable ophthalmic therapies accessible to patients globally. Our focus is on developing targeted treatments that address the underlying causes of vision loss and help patients see a clearer, brighter future.